Dec-92 -

Breast Group

EORTC 10801 – Phase III trial comparing mastectomy to tumorectomy.

A landmark EORTC study that compared two treatment regimens in patients with stage II breast cancer, and found that although mastectomy was slightly better at local control, it did not translate to better survival rates compared to breast-conserving therapy. This finding was important and changed the standard of practice for patients overall quality of life, while at the same time helped clinicians better inform their patients of their options.


Go to Top